Red List

CUECue Biopharma, Inc.

Healthcare · Biotechnology · micro-cap ($120M)
-45.9%
from rolling 252-day high of $45.50 set 2026-07-10 · 41d ago
Current
$24.61
Decline depth
-45.9%
Decline σ
4.0σ
TFC
1/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$CUE landed on the list 2026-04-24, down 42.7% from its 52-week high that day — now down -45.9%.

It has clawed back 20.3 percentage points off that level. It bottomed 59.7% below that high along the way.

Decline from the 52-week high as it stood on 2026-04-24 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

CUE qualifies for the Red List on decline depth.

Decline depth
-45.9%
From rolling 252-day high of $45.50, 41d ago. Past the 40% Red List threshold.
Time-frame continuity
1/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
4.0σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (7.29% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about CUE.

CUE qualifies for the Red List on decline depth — down -45.9% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy. Depth plus recency: this is the pattern many investors call a falling knife.

Cross-confirmation: decline sigma also reads 4.0σ over 5 bars.

Questions about CUE

What people ask.

Why is CUE on Broken Stocks?

CUE qualifies for the Red List on decline depth. It is down -45.9% from its rolling 252-day high of $45.50, set on 2026-07-10 — 41d ago.

Is CUE a falling knife?

By the most common technical definition — a steep, recent breakdown from a fresh high — yes. CUE is down -45.9% from its 52-week high of $45.50, set 41d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.

Is CUE a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is CUE trading inside its 52-week range?

At $24.61, CUE sits 53.9% of the way from its 52-week low ($4.98) to its 52-week high ($41.42). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has CUE been declining?

The current 45.9% decline accrued over 41d, which annualizes to roughly -408.6% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does CUE compare to its sector?

There are 143 other Healthcare tickers on Broken Stocks: 69 Red, 35 Amber, 39 Watch, with 50 showing recovering structural signals. Median sector decline is -36.1% — CUE's decline is deeper than the sector median.